Search Results - "SCHROLNBERGER, C."

Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis by BRUNNER, M., VOGELSANG, H., GREINWALD, R., KLETTER, K., KVATERNIK, H., SCHROLNBERGER, C., EICHLER, H.‐G., BRUNNER, H., DUDCZAK, R., MÜLLER, M.

“…Summary Background : Local treatment with foams in patients suffering from ulcerative proctitis or proctosigmoiditis is considered a rational treatment option…”
Get full text

Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia by Joukhadar, C, Klein, N, Prinz, M, Schrolnberger, C, Vukovich, T, Wolzt, M, Schmetterer, L, Dorner, G T

“…Previous studies have suggested that statins exert beneficial effects beyond their favorable lipid lowering effect. Particularly, the modification of thrombus…”
Get more information

Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer by MADER, R. M, SCHROLNBERGER, C, RIZOVSKI, B, BRUNNER, M, WENZEL, C, LOCKER, G, EICHLER, H. G, MUELLER, M, STEGER, G. G

“…Capecitabine is an oral prodrug of 5-fluorouracil (FU). Since FU concentrations achieved in malignant lesions are an important determinant of efficacy, we…”
Get full text

Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer by Mader, R M, Schrolnberger, C, Rizovski, B, Brunner, M, Wenzel, C, Locker, G, Eichler, H G, Mueller, M, Steger, G G

Get more information

Target Site Concentrations of Ciprofloxacin after Single Intravenous and Oral Doses by BRUNNER, Martin, STASS, Heino, MÖLLER, Jan-Georg, SCHROLNBERGER, Claudia, EROVIC, Boban, HOLLENSTEIN, Ursula, ZEITLINGER, Markus, EICHLER, Hans Georg, MÜLLER, Markus

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Penetration of dacarbazine and its active metabolite 5‐aminoimidazole‐4‐carboxamide into cutaneous metastases of human malignant melanoma by Joukhadar, Christian, Klein, Nikolas, Mader, Robert M., Schrolnberger, Claudia, Rizovski, Blanka, Heere‐Ress, Elisabeth, Pehamberger, Hubert, Strauchmann, Nadja, Jansen, Burkhard, Müller, Markus

“…BACKGROUND Dacarbazine has been on the market for approximately 3 decades but remains the most effective single agent available for the therapy of metastatic…”
Get full text

Application of the minimal trauma tissue biopsy to transdermal clinical pharmacokinetic studies by Schrolnberger, Claudia, Brunner, Martin, Mayer, Bernhard X., Eichler, Hans G., Müller, Markus

“…Although the transdermal administration of drugs has gained considerable importance, reliable methods for the quantitative assessment of transdermal drug…”
Get full text

Penetration of capecitabine and its metabolites into malignant and healthy tissue from patients with advanced breast cancer by Mader, R.M., Schrolnberger, C., Rizovski, B., Brunner, M., Wenzel, C., Locker, G., Schmidinger, M., Eichler, H.G., Mueller, M., Steger, G.G.

Get full text

Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment by JOUKHADAR, Christian, HERRANZ, Ursula, PERNERSTORFER, Thomas, ASSANDRI, Alessandro, KLEIN, Nikolas, SCHROLNBERGER, Claudia, LACKNER, Edith, EICHLER, Hans G, MÜLLER, Markus

“…Emedastine difumarate is a new H1 receptor antagonist with well defined pharmacokinetic and pharmacodynamic profiles in healthy volunteers. However, to date it…”
Get full text